Secretory Leukocyte Protease Inhibitor Binds to Neisseria gonorrhoeae Outer Membrane Opacity Protein and is Bactericidal

American Journal of Reproductive Immunology

Volumn 68, Issue 2, 2012, Pages 116-127

  Cooper, Morris D ^a   Roberts, Melissa H ^a   Barauskas, Ona L ^b   Jarvis, Gary A ^b,c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antimicrobial peptide; Epithelial cell; Gonorrhea; Neisseria gonorrhoeae; Reproductive tract

Indexed keywords

MESSENGER RNA; OUTER MEMBRANE OPACITY PROTEIN; OUTER MEMBRANE PROTEIN; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BINDING SITE; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAR WESTERN BLOTTING; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT;

BACTERIAL OUTER MEMBRANE PROTEINS; CELL LINE; GENE EXPRESSION REGULATION; GONORRHEA; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; NEISSERIA GONORRHOEAE; PROTEIN BINDING; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; UROGENITAL SYSTEM;

EID: 84863866919     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2012.01149.x     Document Type: Article

References (72)

1. Tapsall JW : Antibiotic resistance in Neisseria gonorrhoeae Clin Infect Dis 2005; 41(Suppl. 4):S263-S268.
2. Walker CK, Sweet RL : Gonorrhea infection in women: prevalence, effects, screening, and management. Int J Womens Health 2011; 3:197-206.
3. Jaiyeoba O, Lazenby G, Soper DE : Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther 2011; 9:61-70.
4. Deguchi T, Nakane K, Yasuda M, Maeda S : Emergence and spread of drug resistant Neisseria gonorrhoeae J Urol 2010; 184:851-858.
5. Zhu W, Chen CJ, Thomas CE, Anderson JE, Jerse AE, Sparling PF : Vaccines for gonorrhea: can we rise to the challenge? Front Microbiol 2011; 2:124.
6. Johnson LF, Lewis DA : The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis 2008; 35:946-959.
7. Kalichman SC, Pellowski J, Turner C : Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect 2011; 87:183-190.
8. Griffiss JM, Lammel CJ, Wang J, Dekker NP, Brooks GF : Neisseria gonorrhoeae coordinately uses Pili and Opa to activate HEC-1-B cell microvilli, which causes engulfment of the gonococci. Infect Immun 1999; 67:3469-3480.
9. Spear GT, Kendrick SR, Chen HY, Thomas TT, Bahk M, Balderas R, Ghosh S, Weinberg A, Landay AL : Multiplex immunoassay of lower genital tract mucosal fluid from women attending an urban STD clinic shows broadly increased IL1β and lactoferrin. PLoS ONE 2011; 6:e19560.
10. Pridmore AC, Jarvis GA, John CM, Jack DL, Dower SK, Read RC : Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strains. Infect Immun 2003; 71:3901-3908.
11. Fisette PL, Ram S, Andersen JM, Guo W, Ingalls RR : The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-κB activation in epithelial cells in a Toll-like receptor 2-dependent manner. J Biol Chem 2003; 278:46252-46260.
12. Massari P, Henneke P, Ho Y, Latz E, Golenbock DT, Wetzler LM : Cutting edge: immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J Immunol 2002; 168:1533-1537.
13. Wira CR, Ghosh M, Smith JM, Shen L, Connor RI, Sundstrom P, Frechette GM, Hill ET, Fahey JV : Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus Mucosal Immunol 2011; 4:335-342.
14. Draper DL, Landers DV, Krohn MA, Hillier SL, Wiesenfeld HC, Heine RP : Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol 2000; 183:1243-1248.
15. Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, Yip KP, Mok SC : Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 1998; 152:1247-1258.
16. Klotman ME, Rapista A, Teleshova N, Micsenyi A, Jarvis GA, Lu W, Porter E, Chang TL : Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission. J Immunol 2008; 180:6176-6185.
17. Sallenave JM : Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity. Am J Respir Cell Mol Biol 2010; 42:635-643.
18. Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH : Antibacterial activity of antileukoprotease. Infect Immun 1996; 64:4520-4524.
19. Si-Tahar M, Merlin D, Sitaraman S, Madara JL : Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells. Gastroenterology 2000; 118:1061-1071.
20. Gomez SA, Arguelles CL, Guerrieri D, Tateosian NL, Amiano NO, Slimovich R, Maffia PC, Abbate E, Musella RM, Garcia VE, Chuluyan HE : Secretory leukocyte protease inhibitor: a secreted pattern recognition receptor for mycobacteria. Am J Respir Crit Care Med 2009; 179:247-253.
21. Pillay K, Coutsoudis A, Agadzi-Naqvi AK, Kuhn L, Coovadia HM, Janoff EN : Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 2001; 183:653-656.
22. Quan DN, Cooper MD, Potter JL, Roberts MH, Cheng H, Jarvis GA : TREM-2 binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cells. Mucosal Immunol 2008; 1:229-238.
23. Jarvis GA, Li J, Swanson KV : Invasion of human mucosal epithelial cells by Neisseria gonorrhoeae upregulates expression of intercellular adhesion molecule 1 (ICAM-1). Infect Immun 1999; 67:1149-1156.
24. Liu M, John CM, Jarvis GA : Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathways. J Immunol 2010; 185:6974-6984.
25. Schneider H, Griffiss JM, Williams GD, Pier GB : Immunological basis of serum resistance of Neisseria gonorrhoeae J Gen Microbiol 1982; 128:13-22.
26. Kellogg DS, Cohen IR, Norins LC, Schroeter AL, Reising G : Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol 1968; 96:596-605.
27. Swanson J, Robbins K, Barrera O, Corwin D, Boslego J, Ciak J, Blake M, Koomey JM : Gonococcal pilin variants in experimental gonorrhea. J Exp Med 1987; 165:1344-1357.
28. Zollinger WD, Mandrell RE, Griffiss JM, Altieri P, Berman S : Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J Clin Invest 1979; 63:836-848.
29. Jiménez C, Huang L, Qiu Y, Burlingame AL : In-gel digestion of proteins for MALDI-MS fingerprint mapping. In Current Protocols in Protein Science, JE Coligan, BM Dunn, DW Speicher, PT Windfield (eds). Somerset, NJ, John Wiley & Sons, 2006, pp 16.4.2-16.4.4.
30. Ross SC, Densen P : Opsonophagocytosis of Neisseria gonorrhoeae: interaction of local and disseminated isolates with complement and neutrophils. J Infect Dis 1985; 151:33-41.
31. Swanson KV, Jarvis GA, Brooks GF, Barham BJ, Cooper MD, Griffiss JM : CEACAM is not necessary for Neisseria gonorrhoeae to adhere to and invade female genital epithelial cells. Cell Microbiol 2001; 3:681-691.
32. Fahey JV, Humphrey SL, Stern JE, Wira CR : Secretory component production by polarized epithelial cells from the human female reproductive tract. Immunol Invest 1998; 27:167-180.
33. -ΔΔC T Method. Methods 2001; 25:402-408.
34. Kerwood DE, Schneider H, Yamasaki R : Structural analysis of lipooligosaccharide produced by Neisseria gonorrhoeae, strain MS11mk (variant A): a precursor for a gonococcal lipooligosaccharide associated with virulence. Biochemistry 1992; 31:12760-12768.
35. Kupsch EM, Knepper B, Kuroki T, Heuer I, Meyer TF : Variable opacity (Opa) outer membrane proteins account for the cell tropisms displayed by Neisseria gonorrhoeae for human leukocytes and epithelial cells. EMBO J 1993; 12:641-650.
36. Huttner KM, Bevins CL : Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res 1999; 45:785-794.
37. Hickey DK, Patel MV, Fahey JV, Wira CR : Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 2011; 88:185-194.
38. Singh PK, Tack BF, McCray Jr PB, Welsh MJ : Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol 2000; 279:L799-L805.
39. Moriyama A, Shimoya K, Kawamoto A, Hashimoto K, Ogata I, Kunishige I, Ohashi K, Azuma C, Saji F, Murata Y : Secretory leukocyte protease inhibitor (SLP) concentrations in seminal plasma: SLPI restores sperm motility reduced by elastase. Mol Hum Reprod 1998; 4:946-950.
40. Liao M, Ruddock PS, Rizvi AS, Hall SH, French FS, Dillon JR : Cationic peptide of the male reproductive tract, HE2α, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis J Antimicrob Chemother 2005; 56:957-961.
41. Goytia M, Shafer WM : Polyamines can increase resistance of Neisseria gonorrhoeae to mediators of the innate human host defense. Infect Immun 2010; 78:3187-3195.
42. Lewis LA, Ram S, Prasad A, Gulati S, Getzlaff S, Blom AM, Vogel U, Rice PA : Defining targets for complement components C4b and C3b on the pathogenic neisseriae. Infect Immun 2008; 76:339-350.
43. Akira S, Uematsu S, Takeuchi O : Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
44. Dewald AH, Hodges JC, Columbus L : Physical determinants of β-barrel membrane protein folding in lipid vesicles. Biophys J 2011; 100:2131-2140.
45. Dehio C, Gray-Owen SD, Meyer TF : The role of neisserial Opa proteins in interactions with host cells. Trends Microbiol 1998; 6:489-495.
46. Bhat KS, Gibbs CP, Barrera O, Morrison SG, Jahnig F, Stern A, Kupsch EM, Meyer TF, Swanson J : The opacity proteins of Neisseria gonorrhoeae strain MS11 are encoded by a family of 11 complete genes. Mol Microbiol 1991; 5:1889-1901.
47. Dempsey JA, Litaker W, Madhure A, Snodgrass TL, Cannon JG : Physical map of the chromosome of Neisseria gonorrhoeae FA1090 with locations of genetic markers, including opa and pil genes. J Bacteriol 1991; 173:5476-5486.
48. Black WJ, Schwalbe RS, Nachamkin I, Cannon JG : Characterization of Neisseria gonorrhoeae protein II phase variation by use of monoclonal antibodies. Infect Immun 1984; 45:453-457.
49. Barritt DS, Schwalbe RS, Klapper DG, Cannon JG : Antigenic and structural differences among six proteins II expressed by a single strain of Neisseria gonorrhoeae Infect Immun 1987; 55:2026-2031.
50. Schmidt KA, Deal CD, Kwan M, Thattassery E, Schneider H : Neisseria gonorrhoeae MS11mkC opacity protein expression in vitro and during human volunteer infectivity studies. Sex Transm Dis 2000; 27:278-283.
51. Connell TD, Shaffer D, Cannon JG : Characterization of the repertoire of hypervariable regions in the Protein II (opa) gene family of Neisseria gonorrhoeae Mol Microbiol 1990; 4:439-449.
52. Sadarangani M, Pollard AJ, Gray-Owen SD : Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria FEMS Microbiol Rev 2011; 35:498-514.
53. + T lymphocytes. Nat Immunol 2002; 3:229-236.
54. Estabrook MM, Jack DL, Klein NJ, Jarvis GA : Mannose-binding lectin binds to two major outer membrane proteins, opacity protein and porin, of Neisseria meningitidis J Immunol 2004; 172:3784-3792.
55. Moriyama A, Shimoya K, Ogata I, Kimura T, Nakamura T, Wada H, Ohashi K, Azuma C, Saji F, Murata Y : Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol Hum Reprod 1999; 5:656-661.
56. James JF, Swanson J : Studies on gonococcus infection. XIII. Occurrence of color/opacity colonial variants in clinical cultures. Infect Immun 1978; 19:332-340.
57. Sweet RL, Blankfort-Doyle M, Robbie MO, Schacter J : The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 1986; 255:2062-2064.
58. Draper DL, James JF, Brooks GF, Sweet RL : Comparison of virulence markers of peritoneal and fallopian tube isolates with endocervical Neisseria gonorrhoeae isolates from women with acute salpingitis. Infect Immun 1980; 27:882-888.
59. Cole JG, Fulcher NB, Jerse AE : Opacity proteins increase Neisseria gonorrhoeae fitness in the female genital tract due to a factor under ovarian control. Infect Immun 2010; 78:1629-1641.
60. Fichorova RN, Anderson DJ : Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 1999; 60:508-514.
61. King AE, Wheelhouse N, Cameron S, McDonald SE, Lee KF, Entrican G, Critchley HO, Horne AW : Expression of secretory leukocyte protease inhibitor and elafin in human fallopian tube and in an in-vitro model of Chlamydia trachomatis infection. Hum Reprod 2009; 24:679-686.
62. Cohen CR, Moscicki AB, Scott ME, Ma Y, Shiboski S, Bukusi E, Daud I, Rebbapragada A, Brown J, Kaul R : Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. AIDS 2010; 24:2069-2074.
63. Fakioglu E, Wilson SS, Mesquita PM, Hazrati E, Cheshenko N, Blaho JA, Herold BC : Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism. J Virol 2008; 82:9337-9344.
64. Wheelhouse N, Wattegedera S, Fleming D, Fitch P, Kelly R, Entrican G : Chlamydia trachomatis and Chlamydophila abortus induce the expression of secretory leukocyte protease inhibitor in cells of the human female reproductive tract. Microbiol Immunol 2008; 52:465-468.
65. Wex T, Treiber G, Venerito M, Leodolter A, Peitz U, Kuester D, Hritz I, Krueger S, Roessner A, Malfertheiner P : Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases. Biol Chem 2006; 387:893-901.
66. Jana NK, Gray LR, Shugars DC : Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity. J Virol 2005; 79:6432-6440.
67. Novak RM, Donoval BA, Graham PJ, Boksa LA, Spear G, Hershow RC, Chen HY, Landay A : Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol 2007; 14:1102-1107.
68. Draper D, Donohoe W, Mortimer L, Heine RP : Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor. J Infect Dis 1998; 178:815-819.
69. Taggart CC, Lowe GJ, Greene CM, Mulgrew AT, O'Neill SJ, Levine RL, McElvaney NG : Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor. J Biol Chem 2001; 276:33345-33352.
70. Cox SW, Rodriguez-Gonzalez EM, Booth V, Eley BM : Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis. J Periodontal Res 2006; 41:477-485.
71. Duncan JA, Gao X, Huang MT, O'Connor BP, Thomas CE, Willingham SB, Bergstralh DT, Jarvis GA, Sparling PF, Ting JP : Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol 2009; 182:6460-6469.
72. Jones A, Geörg M, Maudsdotter L, Jonsson AB : Endotoxin, capsule, and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37. J Bacteriol 2009; 191:3861-3868.